Tag: Chemotherapy
Osimertinib + Chemo Improves Progression-Free Survival in Advanced NSCLC
Greater incidence of grade 3 or higher adverse events from any cause seen in combination group versus monotherapy
Pembrolizumab + Standard Chemotherapy Beneficial in Mesothelioma
Improvement in overall survival seen for patients receiving cisplatin or carboplatin with pemetrexed
Vitamin D Insufficiency Linked to Paclitaxel-Induced Neuropathy
Pretreatment vitamin D insufficiency linked to increased incidence of grade ≥3 chemotherapy-induced peripheral neuropathy
ESMO: Pembrolizumab + Chemo, Trastuzumab Beneficial in Gastroesophageal Cancer
Improvement seen in progression-free survival with add-on pembrolizumab in gastroesophageal junction adenocarcinoma
NCCN: Cancer Centers Still Experiencing Shortages of Chemo Drugs
Overall, 72 and 59 percent of 26 cancer centers reported shortages in carboplatin and cisplatin
Gemcitabine, Cisplatin, Nivolumab Facilitate Bladder Sparing
Clinical complete response of 43 percent seen for those with muscle-invasive bladder cancer receiving neoadjuvant gemcitabine, cisplatin, plus nivolumab
Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin
More than twofold increase in risk seen for those treated with ≥200 mg/m² cumulative doxorubicin versus no doxorubicin
Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer
Although relative dose intensity similar, pathologic complete response higher with intervention
Fewer Complications Seen With Vitamin C, D Supplementation in AML
Overall survival did not differ, but significant interaction found between supplementation and NPM1 with survival
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
Risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia elevated, but risks lower in recent years
